Fundraising FoxFACIT (Fight Against Cancer Innovation Trust)
Impact investorToronto · Pre-Seed–Series A · 16 people tracked
Find your way into FACIT (Fight Against Cancer Innovation Trust)
Sign up to see every warm intro you have to FACIT (Fight Against Cancer Innovation Trust)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FACIT (Fight Against Cancer Innovation Trust) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
FACIT focuses on funding and growing Ontario oncology and health innovation ventures to benefit patients and the provincial economy. Established by the Ontario Institute for Cancer Research (OICR), it supports commercialization, technology transfer and development of cancer research, aiming to attract more R&D investment to Ontario and bring the best oncology innovations to market. Its investments have generated partnerships, clinical trials, job creation and leveraged financing across the province. FACIT also runs a pitch competition (Falcons' Fortunes) and awards, and works alongside OICR to advance cancer solutions that help patients live longer, healthier lives.
Source: firm website, verified Sep 26, 2026.
Team · 16 people
from the firm's website & curated & public directories
What they invest in
from 16 of 53 portfolio companiesHealthtech ×12Medical Devices ×11Biotech ×10Deep Tech ×4AI & Machine Learning ×3Digital Health ×3Hardware ×2Cybersecurity ×1
HQs:Canada×5United States×2
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×42 founders×43 founders×2
Where their founders studiedfrom 10 founders with education data
University of Toronto ×4University of Waterloo ×2
What their founders studiedfrom 10 founders with field-of-study data
Engineering ×4Business & Management ×3Life Sciences ×3
Investments · 53 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 32022 · 17 dated
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.
BiotechDeep TechHealthtechMedical DevicesMississauga
Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)
BoardJean-Francois Pariseau(Director)Damian Lamb(Director)
Co-investorsCTI Life Sciences Fund L.P.Genesys Capital
DNAstack builds Omics AI, a software suite that lets data custodians connect, protect, and share omics and health data across federated networks while enabling researchers to discover, access, and analyze it with AI tools.
AI & Machine LearningBiotechDigital HealthToronto, CA
Miro Cupak(Founder)in
Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.
BiotechDeep TechMedical DevicesToronto, CA
Brian Lichty(Founder, CEO)inCarolina Ilkow(Founder, CSO)inJohn Bell(Founder, President)in
Co-investorsOntario Centre of InnovationOntario Centre of Innovation programs
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
John Valliant(Founder)in
Co-investorsHealthCapLumira VenturesPivotal Life SciencesSeroba Life SciencesVenture OntarioYsios Capital+6 more
Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists.
Digital HealthFemTechHealthtechMedical Devices
Rachel Bartholomew(CEO & Founder)inKamyar Rounidej(Former Co-founder & first Chief Technical Officer)
Co-investorsAltitude AngelsBacchus Venture CapitalBeresford VenturesSOSVThe 51 VenturesWomen's Equity Lab+3 more
KA Imaging develops X-ray imaging technologies and systems, including dual-energy radiography, phase contrast micro-CT, and amorphous selenium detectors.
HardwareHealthtechMedical DevicesWaterloo, CA
Karim S. Karim(Chief Technology Officer (CTO), Co-founder)inSina Ghanbarzadeh(Co-founder & Design Team Lead)inAmol Karnick(President & CEO)inPhilip Templeton(Chief Medical Officer (CMO))in
Co-investorsCreative Destruction Lab (CDL)In-Q-TelLauder PartnersNorthspring Capital Partners
NodeAI is a healthcare-focused company that builds algorithms and runs clinical trials with the aim of raising the standard of medical care.
AI & Machine LearningDigital HealthHealthtechMedical DevicesToronto, CA
Waël Hanna(Co-Founder / President & Chief Medical Officer)inAnthony Gatti(Co-Founder / Chief Technology Officer)inMackensey Bacon(Co-Founder / Chief Executive Officer)in
Co-investorsOntario Centre of InnovationOntario Centre of Innovation programs
Privacy Analytics provides data anonymization technology, advisory services, and tailored solutions to help organizations safely combine, share, and reuse sensitive personal data while managing privacy risk and meeting regulatory requirements.
CybersecurityData & InfrastructureHealthtech
Co-investorsVanedge CapitalVanedge Capital Limited Partnership
ProTgen is a clinical-stage biotechnology company developing targeted Notch activators that generate progenitor T cells to restore thymic function and adaptive immune competence.
BiotechHealthtechToronto
Juan Carlos Zuniga-Pflucker(Executive Officer, Director)
BoardFei Shen(Director)Ferdinand Massari(Director)
Co-investorsEisai Innovation, Inc.Boehringer Ingelheim Venture Fund
Qurcan develops veterinary pharmaceutical technology, with leadership holding advanced degrees in veterinary medicine, pharmaceutical sciences, and business development.
BiotechDeep TechHealthtechMedical DevicesCambridge, US
Mohammad Ali Amini(Chief Executive Officer)inShirley Wu(Chief Scientific Officer)John Reid(Chief Business Officer)
Co-investorsToronto Innovation Acceleration Partners
Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs.
Deep TechHealthtechMedical Devices
Alla ReznikAndrew DeanCarmel Shields
BoardWayne Schnarr
Co-investorsToronto Innovation Acceleration Partners
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Co-investorsToronto Innovation Acceleration PartnersAmplitude Venture CapitalBill & Melinda Gates Foundation
Tenomix develops intelligent automation technology for cancer diagnostics and healthcare labs to improve diagnostic speed and accuracy while addressing staffing shortages and rising patient caseloads.
AI & Machine LearningHealthtechMedical DevicesRoboticsLondon, CA
Dr. (unnamed - identified as founder with Ph.D. in Pathology and Laboratory Medicine)(Founder & CEO)Dr. (unnamed - identified as physician-scientist with MD and PhD)(Co-founder)
Co-investorsOntario Centre of Innovation
BiotechNew York, US
Michael Burgess(Executive Officer)Jose Manuel Otero(Executive Officer)Robert Gould(Director)inJane Henderson(Executive Officer)inStefan Larson(Director)Patrick Machado(Director)
Co-investorsBrace PharmaF-Prime CapitalFoothill VenturesVenture OntarioOrbiMedPoint72+1 more
Xpan develops a single universal trocar for minimally invasive surgery (MIS) that accommodates all surgical instruments, aiming to replace traditional trocar access.
BiotechHardwareHealthtechMedical DevicesNobleton
Suresh Pai(Co-Founder & Board Director)inZaid Atto(Founder & CEO)in
Co-investorsUniversity of Toronto Entrepreneurship Hatchery
Yellowbird Diagnostics develops plug-and-play imaging dyes for common medical imaging procedures, designed to reveal disease markers for earlier diagnosis of conditions affecting the brain, heart, and kidneys.
BiotechHealthtechMedical Devices
Co-investorsFront Row Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
16-Bit20/20 OptimEyes TechnologiesAI VALI IncAIGA TherapeuticsAir Microfluidic Systems IncArcticDxArrayus TechnologiesBridge7 OncologyCapnosticscTRL TherapeuticsCura TherapeuticsDalriada TherapeuticsDLVR TherapeuticsdoctalkDVS SciencesESI ImagingFluorinov PharmaFocusOnCareGenetics AdviserHDAX TherapeuticsKapplexKlondike BiopharmaMultimagnetics IncMyellama TherapeuticsNotch TherapeuticsNovera TherapeuticsPattern PharmaPoint Surgical IncPolumirosPrecisionXRTPropellon TherapeuticsReplica AnalyticsTalon PharmaceuticalsVirano TherapeuticsXagenicXLV DiagnosticsZiliomics
Exits · 3
1 IPOs · 2 acquisitionsProfound MedicalNASDAQ: PROFDVS Sciencesacq. by Fluidigm Corp.Fluorinov Pharmaacq. by Trillium Therapeutics
Portfolio news
latest coverage across their companiesProfound Medical · stocktitan.net · Sep 3, 2026
Yellowbird Diagnostics · finance.yahoo.com · Apr 20, 2026
Frequently asked questions
- How many investments has FACIT (Fight Against Cancer Innovation Trust) made?
- FACIT (Fight Against Cancer Innovation Trust) has 53 tracked investments, 3 of which have exited, including 4 dated in the last 24 months.
- What stage does FACIT (Fight Against Cancer Innovation Trust) invest at?
- FACIT (Fight Against Cancer Innovation Trust) invests at the Pre-Seed, Seed, Series A stages.
- What is FACIT (Fight Against Cancer Innovation Trust)'s typical check size?
- FACIT (Fight Against Cancer Innovation Trust) typically writes checks of $1.1M.
- What sectors does FACIT (Fight Against Cancer Innovation Trust) focus on?
- FACIT (Fight Against Cancer Innovation Trust) focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is FACIT (Fight Against Cancer Innovation Trust) located?
- FACIT (Fight Against Cancer Innovation Trust) is headquartered in Toronto, CA.
- Who does FACIT (Fight Against Cancer Innovation Trust) co-invest with?
- FACIT (Fight Against Cancer Innovation Trust) most often shares deals with Creative Destruction Lab (CDL), Toronto Innovation Acceleration Partners, Ontario Centre of Innovation, among 33 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.